Hepatitis D - 32 Studies Found

Completed : Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
:
  • Hepatitis D, Chronic
  • Hepatitis B, Chronic

: 2008-05-27
: Biological: Peginterferon alfa-2b (PegIntron, SCH 54031) Peginterferon alfa-2b 1.5 mcg/kg/wk subcutaneou
Terminated : Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic HBV
:
  • Hepatitis B
  • Hepatitis D

: 2015-10-14
:
  • Drug: ARC-520
  • Drug: Entecavir

Active, not recruiting : REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection
: Chronic HBV Infection (HBeAg Negative)
: 2014-09-01
: Drug: REP 2139-Ca + Pegasys (TM) 15 weeks of REP 2139-Ca (500mg QW IV) followed by: 15 weeks of REP 2139
Active, not recruiting : Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
:
  • Chronic Hepatitis B
  • Chronic Hepatitis D

: 2005-06-30
: Drug: pegylated IFN alfa-2b plus ribavirin
Completed : Hepatitis Delta Infections in Hemophiliacs
:
  • Blood Disease
  • Hepatitis, Viral, Human
  • Liver Diseases

    • : 2000-05-25
    : Other: No interventions - observational study
Completed : Lamivudine for Chronic Hepatitis B
:
  • Chronic Hepatitis B
  • Chronic Hepatitis D